In vitro MicroFlow kits allow researchers the ability to easily score micronucleus samples early in the drug discovery process. With low test article requirements and rapid screening of potential drug candidates, this method offers enormous benefits for lead optimization.

These In vitro kits provide a good bridge to the required in vivo micronucleus test, while also making it possible for any researcher to incorporate this well established genetic toxicity endpoint into a study. It is no longer necessary to use a dedicated, experienced microscopist to examine MN formation.

Who Should Use MicroFlow Kits?

• Pharmaceutical companies (preclinical testing)
• Contract Research and Testing Organizations
• Biotechnology research organizations
• University/Academic research laboratories
• Government institutes and the military
• Medical/Dental Device manufacturers
• Chemical and Tobacco Companies

For researchers who work within very tight time constraints, faster and more reliable testing can be the difference between breakthroughs and disappointments.